Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
13
pubmed:dateCreated
1996-8-23
pubmed:abstractText
Apolipoprotein (apo)-B is found in two forms in mammals: apo-B100, which is made in the liver and the yolk sac, and apo-B48, a truncated protein made in the intestine. To provide models for understanding the physiologic purpose for the two forms of apo-B, we used targeted mutagenesis of the apo-B gene to generate mice that synthesize exclusively apo-B48 (apo-B48-only mice) and mice that synthesize exclusively apo-B100 (apo-B100-only mice). Both the apo-B48-only mice and apo-B100-only mice developed normally, were healthy, and were fertile. Thus, apo-B48 synthesis was sufficient for normal embryonic development, and the synthesis of apo-B100 in the intestines of adult mice caused no readily apparent adverse effects on intestinal function or nutrition. Compared with wild-type mice fed a chow diet, the levels of low density lipoprotein (LDL)-cholesterol and very low density lipoprotein- and LDL-triacylglycerols were lower in apo-B48-only mice and higher in the apo-B100-only mice. In the setting of apo-E-deficiency, the apo-B100-only mutation lowered cholesterol levels, consistent with the fact that apo-B100-lipoproteins can be cleared from the plasma via the LDL receptor, whereas apo-B48-lipoproteins lacking apo-E cannot. The apo-B48-only and apo-B100-only mice should prove to be valuable models for experiments designed to understand the purpose for the two forms of apo-B in mammalian metabolism.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-1542669, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-1584779, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-1672446, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-1730641, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-1977530, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-1996101, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-2205396, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-3766953, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-3949756, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-6368590, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-6584917, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-7560099, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-7878058, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-7961918, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-8254057, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-8268981, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-8409768, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-8460149, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-8496659, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-8626621, http://linkedlifedata.com/resource/pubmed/commentcorrection/8692825-9026532
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
25
pubmed:volume
93
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6393-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.
pubmed:affiliation
Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94141-9100, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't